Patents by Inventor Matthew Manganiello

Matthew Manganiello has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220175968
    Abstract: Provided herein are compositions and methods for delivering non-viral, capsid-free DNA vectors (ceDNA) to cytosol of a target cell in subject while reducing or inhibiting an immune response.
    Type: Application
    Filed: March 6, 2020
    Publication date: June 9, 2022
    Inventors: Matthew G. Stanton, Matthew Manganiello
  • Publication number: 20140235790
    Abstract: Provided herein are compositions and methods for intracellular delivery. The compositions are polymer compositions in which the polymer serves as a carrier for therapeutic and/or diagnostic agents. The polymer compositions are effective in targeted delivery of therapeutic and/or diagnostic agents to a cell. The polymer compositions include a targeting moiety that includes carbohydrate groups that effectively target specific cell surface receptors. The polymer compositions also include an agent binding moiety that effectively associates the therapeutic and/or diagnostic agent to be delivered to the cell.
    Type: Application
    Filed: June 11, 2012
    Publication date: August 21, 2014
    Applicant: University of Washington through its Center for Commercialization
    Inventors: Patrick Stayton, Matthew Manganiello, Anthony Convertine, Daniel M. Ratner, Yu-Hua Chow, Eun-Ho Song, Bilal Ghosn, Lynn Schnapp, Salka Keller, Debashish Roy